Attenuation of angiotensin II- and III-induced aldosterone release by prostaglandin synthesis inhibitors

W. B. Campbell, C. E. Gomez-Sanchez, B. V. Adams, J. M. Schmitz, H. D. Itskovitz

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

The effect of two prostaglandin synthesis inhibitors, indomethacin and meclofenamate, on angiotensin II (AII)- and III (AIII)-induced aldosterone release was studied in normal and sodium-depleted conscious rats and in adrenal capsular cell suspensions obtained from normal rats. In normal rats, in vivo AII and AIII were equipotent in causing dose-related increases in serum aldosterone concentrations. Indomethacin decreased the basal serum aldosterone levels by 50% and serum renin levels by 43%. In addition, the steroidogenic effects of AII and AIII were reduced by 45 and 63% with 3 mg/kg of indomethacin and 63 and 73% with 10 mg/kg, respectively. In contrast, meclofenamate failed to alter basal serum levels of aldosterone or AII-stimulated aldosterone release but inhibited serum renin levels by 27% and the aldosterone-stimulating effect of AIII by 99%. Indomethacin (3 mg/kg) and meclofenamate (2 mg/kg) inhibited urinary prostaglandin (PG)E2 and PGF2α excretion by 63 and 52% and 37 and 31%, respectively. Both inhibitors significantly decreased the adrenal capsular PGE2 and PGF2α content and the conversion of [14C]arachidonate to [14C]PGE2 and [14C]PGF2α. In sodium-depleted rats, indomethacin produced similar effects reducing the control serum aldosterone levels by 29%, AII-stimulated aldosterone by 47%, and completely suppressing the aldosterone response to AIII without altering serum renin activity. In adrenal cell suspensions, similar results were observed with indomethacin inhibiting basal and AII- and AIII-stimulated aldosterone release by 29, 81, and 93%, respectively. Meclofenamate failed to alter basal and AII-stimulated aldosterone release but inhibited that stimulated by AIII by 86%. The present findings suggest that prostaglandins modulate the effects of the renin-angiotensin system by stimulating the release of renin from the kidney and augmenting the steroidogenic effects of AII and AIII in the adrenal cortex.

Original languageEnglish (US)
Pages (from-to)1552-1557
Number of pages6
JournalJournal of Clinical Investigation
Volume64
Issue number6
StatePublished - 1979

Fingerprint

Angiotensin III
Prostaglandin Antagonists
Aldosterone
Angiotensin II
Indomethacin
Meclofenamic Acid
Renin
Dinoprost
Serum
Dinoprostone
Suspensions
Sodium
Adrenal Cortex
Renin-Angiotensin System
Prostaglandins

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Campbell, W. B., Gomez-Sanchez, C. E., Adams, B. V., Schmitz, J. M., & Itskovitz, H. D. (1979). Attenuation of angiotensin II- and III-induced aldosterone release by prostaglandin synthesis inhibitors. Journal of Clinical Investigation, 64(6), 1552-1557.

Attenuation of angiotensin II- and III-induced aldosterone release by prostaglandin synthesis inhibitors. / Campbell, W. B.; Gomez-Sanchez, C. E.; Adams, B. V.; Schmitz, J. M.; Itskovitz, H. D.

In: Journal of Clinical Investigation, Vol. 64, No. 6, 1979, p. 1552-1557.

Research output: Contribution to journalArticle

Campbell, WB, Gomez-Sanchez, CE, Adams, BV, Schmitz, JM & Itskovitz, HD 1979, 'Attenuation of angiotensin II- and III-induced aldosterone release by prostaglandin synthesis inhibitors', Journal of Clinical Investigation, vol. 64, no. 6, pp. 1552-1557.
Campbell, W. B. ; Gomez-Sanchez, C. E. ; Adams, B. V. ; Schmitz, J. M. ; Itskovitz, H. D. / Attenuation of angiotensin II- and III-induced aldosterone release by prostaglandin synthesis inhibitors. In: Journal of Clinical Investigation. 1979 ; Vol. 64, No. 6. pp. 1552-1557.
@article{ad31368d8fea4ad0b610ba8e2150f30b,
title = "Attenuation of angiotensin II- and III-induced aldosterone release by prostaglandin synthesis inhibitors",
abstract = "The effect of two prostaglandin synthesis inhibitors, indomethacin and meclofenamate, on angiotensin II (AII)- and III (AIII)-induced aldosterone release was studied in normal and sodium-depleted conscious rats and in adrenal capsular cell suspensions obtained from normal rats. In normal rats, in vivo AII and AIII were equipotent in causing dose-related increases in serum aldosterone concentrations. Indomethacin decreased the basal serum aldosterone levels by 50{\%} and serum renin levels by 43{\%}. In addition, the steroidogenic effects of AII and AIII were reduced by 45 and 63{\%} with 3 mg/kg of indomethacin and 63 and 73{\%} with 10 mg/kg, respectively. In contrast, meclofenamate failed to alter basal serum levels of aldosterone or AII-stimulated aldosterone release but inhibited serum renin levels by 27{\%} and the aldosterone-stimulating effect of AIII by 99{\%}. Indomethacin (3 mg/kg) and meclofenamate (2 mg/kg) inhibited urinary prostaglandin (PG)E2 and PGF2α excretion by 63 and 52{\%} and 37 and 31{\%}, respectively. Both inhibitors significantly decreased the adrenal capsular PGE2 and PGF2α content and the conversion of [14C]arachidonate to [14C]PGE2 and [14C]PGF2α. In sodium-depleted rats, indomethacin produced similar effects reducing the control serum aldosterone levels by 29{\%}, AII-stimulated aldosterone by 47{\%}, and completely suppressing the aldosterone response to AIII without altering serum renin activity. In adrenal cell suspensions, similar results were observed with indomethacin inhibiting basal and AII- and AIII-stimulated aldosterone release by 29, 81, and 93{\%}, respectively. Meclofenamate failed to alter basal and AII-stimulated aldosterone release but inhibited that stimulated by AIII by 86{\%}. The present findings suggest that prostaglandins modulate the effects of the renin-angiotensin system by stimulating the release of renin from the kidney and augmenting the steroidogenic effects of AII and AIII in the adrenal cortex.",
author = "Campbell, {W. B.} and Gomez-Sanchez, {C. E.} and Adams, {B. V.} and Schmitz, {J. M.} and Itskovitz, {H. D.}",
year = "1979",
language = "English (US)",
volume = "64",
pages = "1552--1557",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "6",

}

TY - JOUR

T1 - Attenuation of angiotensin II- and III-induced aldosterone release by prostaglandin synthesis inhibitors

AU - Campbell, W. B.

AU - Gomez-Sanchez, C. E.

AU - Adams, B. V.

AU - Schmitz, J. M.

AU - Itskovitz, H. D.

PY - 1979

Y1 - 1979

N2 - The effect of two prostaglandin synthesis inhibitors, indomethacin and meclofenamate, on angiotensin II (AII)- and III (AIII)-induced aldosterone release was studied in normal and sodium-depleted conscious rats and in adrenal capsular cell suspensions obtained from normal rats. In normal rats, in vivo AII and AIII were equipotent in causing dose-related increases in serum aldosterone concentrations. Indomethacin decreased the basal serum aldosterone levels by 50% and serum renin levels by 43%. In addition, the steroidogenic effects of AII and AIII were reduced by 45 and 63% with 3 mg/kg of indomethacin and 63 and 73% with 10 mg/kg, respectively. In contrast, meclofenamate failed to alter basal serum levels of aldosterone or AII-stimulated aldosterone release but inhibited serum renin levels by 27% and the aldosterone-stimulating effect of AIII by 99%. Indomethacin (3 mg/kg) and meclofenamate (2 mg/kg) inhibited urinary prostaglandin (PG)E2 and PGF2α excretion by 63 and 52% and 37 and 31%, respectively. Both inhibitors significantly decreased the adrenal capsular PGE2 and PGF2α content and the conversion of [14C]arachidonate to [14C]PGE2 and [14C]PGF2α. In sodium-depleted rats, indomethacin produced similar effects reducing the control serum aldosterone levels by 29%, AII-stimulated aldosterone by 47%, and completely suppressing the aldosterone response to AIII without altering serum renin activity. In adrenal cell suspensions, similar results were observed with indomethacin inhibiting basal and AII- and AIII-stimulated aldosterone release by 29, 81, and 93%, respectively. Meclofenamate failed to alter basal and AII-stimulated aldosterone release but inhibited that stimulated by AIII by 86%. The present findings suggest that prostaglandins modulate the effects of the renin-angiotensin system by stimulating the release of renin from the kidney and augmenting the steroidogenic effects of AII and AIII in the adrenal cortex.

AB - The effect of two prostaglandin synthesis inhibitors, indomethacin and meclofenamate, on angiotensin II (AII)- and III (AIII)-induced aldosterone release was studied in normal and sodium-depleted conscious rats and in adrenal capsular cell suspensions obtained from normal rats. In normal rats, in vivo AII and AIII were equipotent in causing dose-related increases in serum aldosterone concentrations. Indomethacin decreased the basal serum aldosterone levels by 50% and serum renin levels by 43%. In addition, the steroidogenic effects of AII and AIII were reduced by 45 and 63% with 3 mg/kg of indomethacin and 63 and 73% with 10 mg/kg, respectively. In contrast, meclofenamate failed to alter basal serum levels of aldosterone or AII-stimulated aldosterone release but inhibited serum renin levels by 27% and the aldosterone-stimulating effect of AIII by 99%. Indomethacin (3 mg/kg) and meclofenamate (2 mg/kg) inhibited urinary prostaglandin (PG)E2 and PGF2α excretion by 63 and 52% and 37 and 31%, respectively. Both inhibitors significantly decreased the adrenal capsular PGE2 and PGF2α content and the conversion of [14C]arachidonate to [14C]PGE2 and [14C]PGF2α. In sodium-depleted rats, indomethacin produced similar effects reducing the control serum aldosterone levels by 29%, AII-stimulated aldosterone by 47%, and completely suppressing the aldosterone response to AIII without altering serum renin activity. In adrenal cell suspensions, similar results were observed with indomethacin inhibiting basal and AII- and AIII-stimulated aldosterone release by 29, 81, and 93%, respectively. Meclofenamate failed to alter basal and AII-stimulated aldosterone release but inhibited that stimulated by AIII by 86%. The present findings suggest that prostaglandins modulate the effects of the renin-angiotensin system by stimulating the release of renin from the kidney and augmenting the steroidogenic effects of AII and AIII in the adrenal cortex.

UR - http://www.scopus.com/inward/record.url?scp=0018603978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018603978&partnerID=8YFLogxK

M3 - Article

C2 - 500824

AN - SCOPUS:0018603978

VL - 64

SP - 1552

EP - 1557

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 6

ER -